ID

39884

Descrizione

A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas; ODM derived from: https://clinicaltrials.gov/show/NCT01985958

collegamento

https://clinicaltrials.gov/show/NCT01985958

Keywords

versioni (1)
  1. 27/02/20 27/02/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

27 febbraio 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Histological or Cytological Diagnosis of Pancreatic Carcinoma NCT01985958

Inglese

Eligibility Histological or Cytological Diagnosis of Pancreatic Carcinoma NCT01985958

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histological or cytological diagnosis of pancreatic carcinoma
Descrizione

Pancreatic carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0235974
patients ≥ 18 years of age
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
eastern cooperative oncology group (ecog) performance status 0,1,or 2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
patients must have distant metastatic disease (stage 4)
Descrizione

Distant metastasis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1269798
satisfactory organ and bone marrow function as defined by: absolute neutrophil count> 1,000/ul, platelets > 75,000ul hemoglobin > 9 bilirubin ≤ 2.0x the institutional normal upper limit unless secondary to bile duct obstruction by tumor,
Descrizione

Organ function | Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement | Serum total bilirubin measurement | Exception Secondary to Cholestasis | Cholestasis Due to Tumor

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
UMLS CUI [3]
C0948762
UMLS CUI [4]
C0032181
UMLS CUI [5]
C0518015
UMLS CUI [6]
C1278039
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0175668
UMLS CUI [7,3]
C0008370
UMLS CUI [8,1]
C0008370
UMLS CUI [8,2]
C0678226
UMLS CUI [8,3]
C0027651
creatinine ≤ 1.5x the institutional normal upper limit
Descrizione

Creatinine measurement, serum

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201976
serum alanine aminotransferase (alt) or aspartate aminotransferase (ast) ≤ 5x the institutional normal upper limit.
Descrizione

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
a clinical recommendation for radiotherapy to the primary or a metastatic lesion had been made.
Descrizione

Recommendation Therapeutic radiology procedure Primary Lesion | Recommendation Therapeutic radiology procedure Metastatic Lesion

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0034866
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C1402294
UMLS CUI [2,1]
C0034866
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C1513183
must be able to provide informed consent.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
no prior radiation to the area planned for radiotherapy
Descrizione

Prior radiation therapy Area Planned Therapeutic radiology procedure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C0205146
UMLS CUI [1,3]
C1301732
UMLS CUI [1,4]
C1522449
active invasive cancer other than pancreatic adenocarcinoma. non-melanoma skin cancer, superficial cervical or bladder cancer and prostate cancer with psa level < 1.0 are not excluded.
Descrizione

Invasive cancer | Exception Adenocarcinoma of pancreas | Exception Skin carcinoma | Exception Superficial cervix carcinoma | Exception Superficial carcinoma of urinary bladder | Exception Prostate carcinoma PSA Level

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0677898
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0281361
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0699893
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0302592
UMLS CUI [4,3]
C0205124
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1336527
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0600139
UMLS CUI [6,3]
C4086720
known hiv, hcv and/or hbv positive (by patient report/medical record)
Descrizione

HIV Seropositivity | Hepatitis C Virus Positive | Hepatitis B Virus Positive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C4330254
UMLS CUI [3,1]
C0019169
UMLS CUI [3,2]
C1514241
patients with ongoing or active infection
Descrizione

Communicable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
planned concurrent treatment with systemic high dose corticosteroids.
Descrizione

CORTICOSTEROIDS FOR SYSTEMIC USE High dose Planned

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3653708
UMLS CUI [1,2]
C0444956
UMLS CUI [1,3]
C1301732
received an anticancer treatment (systemic therapy or radiation therapy)within 21 days prior to enrollment.
Descrizione

Cancer treatment | Systemic therapy | Therapeutic radiology procedure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C1515119
UMLS CUI [3]
C1522449
immunotherapy (e.g. monoclonal antibodies)within 21 days prior to enrollment.
Descrizione

Immunotherapy | Monoclonal Antibodies

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021083
UMLS CUI [2]
C0003250
immunosuppressive therapies (e.g. steroids, cyclosporine) are not permitted.
Descrizione

Therapeutic immunosuppression | Steroid therapy | Cyclosporine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0149783
UMLS CUI [3]
C0010592
Ritorna all'inizio della pagina

Similar models

Eligibility Histological or Cytological Diagnosis of Pancreatic Carcinoma NCT01985958

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Pancreatic carcinoma
Item
histological or cytological diagnosis of pancreatic carcinoma
boolean
C0235974 (UMLS CUI [1])
Age
Item
patients ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0,1,or 2
boolean
C1520224 (UMLS CUI [1])
Distant metastasis
Item
patients must have distant metastatic disease (stage 4)
boolean
C1269798 (UMLS CUI [1])
Organ function | Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement | Serum total bilirubin measurement | Exception Secondary to Cholestasis | Cholestasis Due to Tumor
Item
satisfactory organ and bone marrow function as defined by: absolute neutrophil count> 1,000/ul, platelets > 75,000ul hemoglobin > 9 bilirubin ≤ 2.0x the institutional normal upper limit unless secondary to bile duct obstruction by tumor,
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0518015 (UMLS CUI [5])
C1278039 (UMLS CUI [6])
C1705847 (UMLS CUI [7,1])
C0175668 (UMLS CUI [7,2])
C0008370 (UMLS CUI [7,3])
C0008370 (UMLS CUI [8,1])
C0678226 (UMLS CUI [8,2])
C0027651 (UMLS CUI [8,3])
Creatinine measurement, serum
Item
creatinine ≤ 1.5x the institutional normal upper limit
boolean
C0201976 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
serum alanine aminotransferase (alt) or aspartate aminotransferase (ast) ≤ 5x the institutional normal upper limit.
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Recommendation Therapeutic radiology procedure Primary Lesion | Recommendation Therapeutic radiology procedure Metastatic Lesion
Item
a clinical recommendation for radiotherapy to the primary or a metastatic lesion had been made.
boolean
C0034866 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C1402294 (UMLS CUI [1,3])
C0034866 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1513183 (UMLS CUI [2,3])
Informed Consent
Item
must be able to provide informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior radiation therapy Area Planned Therapeutic radiology procedure
Item
no prior radiation to the area planned for radiotherapy
boolean
C0279134 (UMLS CUI [1,1])
C0205146 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
Invasive cancer | Exception Adenocarcinoma of pancreas | Exception Skin carcinoma | Exception Superficial cervix carcinoma | Exception Superficial carcinoma of urinary bladder | Exception Prostate carcinoma PSA Level
Item
active invasive cancer other than pancreatic adenocarcinoma. non-melanoma skin cancer, superficial cervical or bladder cancer and prostate cancer with psa level < 1.0 are not excluded.
boolean
C0677898 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0281361 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0302592 (UMLS CUI [4,2])
C0205124 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C1336527 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0600139 (UMLS CUI [6,2])
C4086720 (UMLS CUI [6,3])
HIV Seropositivity | Hepatitis C Virus Positive | Hepatitis B Virus Positive
Item
known hiv, hcv and/or hbv positive (by patient report/medical record)
boolean
C0019699 (UMLS CUI [1])
C4330254 (UMLS CUI [2])
C0019169 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
Communicable Disease
Item
patients with ongoing or active infection
boolean
C0009450 (UMLS CUI [1])
CORTICOSTEROIDS FOR SYSTEMIC USE High dose Planned
Item
planned concurrent treatment with systemic high dose corticosteroids.
boolean
C3653708 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
Cancer treatment | Systemic therapy | Therapeutic radiology procedure
Item
received an anticancer treatment (systemic therapy or radiation therapy)within 21 days prior to enrollment.
boolean
C0920425 (UMLS CUI [1])
C1515119 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
Immunotherapy | Monoclonal Antibodies
Item
immunotherapy (e.g. monoclonal antibodies)within 21 days prior to enrollment.
boolean
C0021083 (UMLS CUI [1])
C0003250 (UMLS CUI [2])
Therapeutic immunosuppression | Steroid therapy | Cyclosporine
Item
immunosuppressive therapies (e.g. steroids, cyclosporine) are not permitted.
boolean
C0021079 (UMLS CUI [1])
C0149783 (UMLS CUI [2])
C0010592 (UMLS CUI [3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial